Tetra Therapeutics
Florham Park, US · 2 known investors
Find your way into Tetra Therapeutics
Tetra Therapeutics (Tetra Discovery Partners) was a discovery-based pharmaceutical company developing clinical programs including treatments for Fragile X Syndrome. It was acquired by Shionogi & Co. in 2020, and its former clinical trials and research programs are now managed by Shionogi Inc., a U.S. subsidiary.
Investors · 2
Frequently asked questions
- What does Tetra Therapeutics do?
- Tetra Therapeutics (Tetra Discovery Partners) was a discovery-based pharmaceutical company developing clinical programs including treatments for Fragile X Syndrome. It was acquired by Shionogi & Co. in 2020, and its former clinical trials and research programs are now managed by Shionogi Inc., a U.S. subsidiary.
- Who are Tetra Therapeutics's investors?
- Tetra Therapeutics's investors include Invest Michigan, Dolby Family Ventures.
- Where is Tetra Therapeutics headquartered?
- Tetra Therapeutics is headquartered in Florham Park, US.